Sowers, M. et al. Changes in body composition in women over six years at midlife: ovarian and chronological aging. J. Clin. Endocrinol. Metab. 92, 895–901 (2007).
Google Scholar
Sowers, M. R. et al. Hormone predictors of bone mineral density changes during the menopausal transition. J. Clin. Endocrinol. Metab. 91, 1261–1267 (2006).
Google Scholar
Guo, Y. et al. Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol. Cell Res. 29, 151–166 (2019).
Google Scholar
Han, X. et al. A novel follicle-stimulating hormone vaccine for controlling fat accumulation. Theriogenology 148, 103–111 (2020).
Google Scholar
Ji, Y. et al. Epitope-specific monoclonal antibodies to FSHβ increase bone mass. Proc. Natl Acad. Sci. USA 115, 2192–2197 (2018).
Google Scholar
Liu, P. et al. Blocking FSH induces thermogenic adipose tissue and reduces body fat. Nature 546, 107–112 (2017).
Google Scholar
Geng, W. et al. Immunization with FSHβ fusion protein antigen prevents bone loss in a rat ovariectomy-induced osteoporosis model. Biochem. Biophys. Res. Commun. 434, 280–286 (2013).
Google Scholar
Fisher, D. W., Bennett, D. A. & Dong, H. Sexual dimorphism in predisposition to Alzheimer’s disease. Neurobiol. Aging 70, 308–324 (2018).
Google Scholar
Andersen, K. et al. Gender differences in the incidence of AD and vascular dementia: the EURODEM studies. EURODEM Incidence Research Group. Neurology 53, 1992–1997 (1999).
Google Scholar
Marongiu, R. Accelerated ovarian failure as a unique model to study peri-menopause influence on Alzheimer’s disease. Front. Aging Neurosci. 11, 242 (2019).
Google Scholar
Matyi, J. M., Rattinger, G. B., Schwartz, S., Buhusi, M. & Tschanz, J. T. Lifetime estrogen exposure and cognition in late life: the Cache County study. Menopause 26, 1366–1374 (2019).
Google Scholar
Zandi, P. P. et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288, 2123–2129 (2002).
Google Scholar
O’Brien, J., Jackson, J. W., Grodstein, F., Blacker, D. & Weuve, J. Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer’s disease. Epidemiol. Rev. 36, 83–103 (2014).
Google Scholar
Shumaker, S. A. et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women’s Health Initiative Memory Study. JAMA 291, 2947–2958 (2004).
Google Scholar
Short, R. A., Bowen, R. L., O’Brien, P. C. & Graff-Radford, N. R. Elevated gonadotropin levels in patients with Alzheimer disease. Mayo Clin. Proc. 76, 906–909 (2001).
Google Scholar
Bowen, R. L., Isley, J. P. & Atkinson, R. L. An association of elevated serum gonadotropin concentrations and Alzheimer disease? J. Neuroendocrinol. 12, 351–354 (2000).
Google Scholar
Randolph, J. F. Jr et al. Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J. Clin. Endocrinol. Metab. 96, 746–754 (2011).
Google Scholar
Epperson, C. N., Sammel, M. D. & Freeman, E. W. Menopause effects on verbal memory: findings from a longitudinal community cohort. J. Clin. Endocrinol. Metab. 98, 3829–3838 (2013).
Google Scholar
Greendale, G. A. et al. Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology 72, 1850–1857 (2009).
Google Scholar
Meyer, P. M. et al. A population-based longitudinal study of cognitive functioning in the menopausal transition. Neurology 61, 801–806 (2003).
Google Scholar
Zhu, L. L. et al. Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis. Proc. Natl Acad. Sci. USA 109, 14574–14579 (2012).
Google Scholar
Oddo, S. et al. Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Aβ and synaptic dysfunction. Neuron 39, 409–421 (2003).
Google Scholar
Webster, S. J., Bachstetter, A. D., Nelson, P. T., Schmitt, F. A. & Van Eldik, L. J. Using mice to model Alzheimer’s dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front. Genet. 5, 88 (2014).
Google Scholar
Carroll, J. C. et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J. Neurosci. 27, 13357–13365 (2007).
Google Scholar
Zhang, Z. et al. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer’s disease. Nat. Med. 20, 1254–1262 (2014).
Google Scholar
Zhang, Z. et al. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease. Nat. Commun. 6, 8762 (2015).
Google Scholar
Rocca, W. A. et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 69, 1074–1083 (2007).
Google Scholar
Tokuyama, N. et al. Individual and combining effects of anti-RANKL monoclonal antibody and teriparatide in ovariectomized mice. Bone Rep. 2, 1–7 (2015).
Google Scholar
Rosen, C. J. & Zaidi, M. Contemporaneous reproduction of preclinical science: a case study of FSH and fat. Ann. N. Y. Acad. Sci. 1404, 17–19 (2017).
Google Scholar
Minkeviciene, R. et al. Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice. J. Neurochem. 105, 584–594 (2008).
Google Scholar
Onos, K. D. et al. Enhancing face validity of mouse models of Alzheimer’s disease with natural genetic variation. PLoS Genet. 15, e1008155 (2019).
Google Scholar
Volianskis, A., Kostner, R., Molgaard, M., Hass, S. & Jensen, M. S. Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1deltaE9-deleted transgenic mice model of ss-amyloidosis. Neurobiol. Aging 31, 1173–1187 (2010).
Google Scholar
Araujo, A. B. & Wittert, G. A. Endocrinology of the aging male. Best Pract. Res. Clin. Endocrinol. Metab. 25, 303–319 (2011).
Google Scholar
Casadesus, G. et al. Increases in luteinizing hormone are associated with declines in cognitive performance. Mol. Cell. Endocrinol. 269, 107–111 (2007).
Google Scholar
Berry, A., Tomidokoro, Y., Ghiso, J. & Thornton, J. Human chorionic gonadotropin (a luteinizing hormone homologue) decreases spatial memory and increases brain amyloid-β levels in female rats. Horm. Behav. 54, 143–152 (2008).
Google Scholar
Liu, T., Wimalasena, J., Bowen, R. L. & Atwood, C. S. Luteinizing hormone receptor mediates neuronal pregnenolone production via up-regulation of steroidogenic acute regulatory protein expression. J. Neurochem. 100, 1329–1339 (2007).
Google Scholar
Gera, S. et al. First-in-class humanized FSH blocking antibody targets bone and fat. Proc. Natl Acad. Sci. USA 117, 28971–28979 (2020).
Google Scholar
Straccia, M. et al. Pro-inflammatory gene expression and neurotoxic effects of activated microglia are attenuated by absence of CCAAT/enhancer binding protein β. J. Neuroinflammation 8, 156 (2011).
Google Scholar
Ramji, D. P. & Foka, P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365, 561–575 (2002).
Google Scholar
Wang, Z. H. et al. Delta-secretase phosphorylation by SRPK2 enhances its enzymatic activity, provoking pathogenesis in Alzheimer’s disease. Mol. Cell 67, 812–825 (2017).
Google Scholar
Sun, L. et al. FSH directly regulates bone mass. Cell 125, 247–260 (2006).
Google Scholar
Hammond, S. L., Leek, A. N., Richman, E. H. & Tjalkens, R. B. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection. PLoS ONE 12, e0188830 (2017).
Google Scholar
von Jonquieres, G. et al. Recombinant human myelin-associated glycoprotein promoter drives selective AAV-mediated transgene expression in oligodendrocytes. Front. Mol. Neurosci. 9, 13 (2016).
Randolph, J. F. Jr. et al. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J. Clin. Endocrinol. Metab. 88, 1516–1522 (2003).
Google Scholar
Ashe, K. H. & Zahs, K. R. Probing the biology of Alzheimer’s disease in mice. Neuron 66, 631–645 (2010).
Google Scholar
Millward, C. A. et al. Mice with a deletion in the gene for CCAAT/enhancer-binding protein β are protected against diet-induced obesity. Diabetes 56, 161–167 (2007).
Google Scholar
Zaidi, M. et al. Actions of pituitary hormones beyond traditional targets. J. Endocrinol. 237, R83–R98 (2018).
Google Scholar
Silverman, E., Eimerl, S. & Orly, J. CCAAT enhancer-binding protein β and GATA-4 binding regions within the promoter of the steroidogenic acute regulatory protein (StAR) gene are required for transcription in rat ovarian cells. J. Biol. Chem. 274, 17987–17996 (1999).
Google Scholar
Sirois, J. & Richards, J. S. Transcriptional regulation of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. Evidence for the role of a cis-acting C/EBPβ promoter element. J. Biol. Chem. 268, 21931–21938 (1993).
Google Scholar
Wang, H., Liu, X., Chen, S. & Ye, K. Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer’s disease. Proc. Natl Acad. Sci. USA 115, E12427–E12434 (2018).
Google Scholar
Sterneck, E., Tessarollo, L. & Johnson, P. F. An essential role for C/EBPβ in female reproduction. Genes Dev. 11, 2153–2162 (1997).
Google Scholar
Minkeviciene, R. et al. Amyloid β-induced neuronal hyperexcitability triggers progressive epilepsy. J. Neurosci. 29, 3453–3462 (2009).
Google Scholar
Zhang, Z. et al. 7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer’s disease. Neuropsychopharmacology 39, 638–650 (2014).
Google Scholar
Xiang, J. et al. Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer’s disease pathologies. Proc. Natl Acad. Sci. USA 116, 9094–9102 (2019).
Google Scholar
Leger, M. et al. Object recognition test in mice. Nat. Protoc. 8, 2531–2537 (2013).
Google Scholar
Ioannidis, J. P. Why most published research findings are false. PLoS Med. 2, e124 (2005).
Google Scholar
Collins, F. S. & Tabak, L. A. Policy: NIH plans to enhance reproducibility. Nature 505, 612–613 (2014).
Google Scholar
McNutt, M. Reproducibility. Science 343, 229 (2014).
Google Scholar
Mullard, A. Cancer reproducibility project yields first results. Nat. Rev. Drug Discov. 16, 77 (2017).
Google Scholar
Horrigan, S. K. et al. Replication study: melanoma genome sequencing reveals frequent PREX2 mutations. eLife 6, e21634 (2017).
Google Scholar
Horrigan, S. K., Reproducibility Project: Cancer Biology. Replication study: the CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. eLife 6, e18173 (2017).
Google Scholar